Beijing Biostar Pharmaceuticals Co., Ltd.

SEHK:2563 Stock Report

Market Cap: HK$11.9b

Beijing Biostar Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Rongguo Qiu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure22.4yrs
CEO ownershipn/a
Management average tenure6.3yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

CEO

Rongguo Qiu (62 yo)

22.4yrs

Tenure

Mr. Rongguo Qiu is Co- Founder of Beijing Biostar Pharmaceuticals Co., Ltd. from July 2002 and serves as its Vice-Chairperson since July 2020 and CEO since March 2021. He serves as Executive Director at Be...

Leadership Team

NamePositionTenureCompensationOwnership
Li Tang
Co-Founder22.4yrsno data0.99%
HK$ 117.7m
Rongguo Qiu
Co- Founder22.4yrsno datano data
Fei Peng
Financial Director2.8yrsno datano data
Xin Chen
Operation Directorno datano datano data
Kailin Liu
Investment Director & Secretary of the Board4.4yrsno datano data
Wei He
Head of administrationno datano datano data
Aoshuang Huang
Human Resource Directorno datano datano data
Cheng Zhang
Deputy GM8.3yrsno datano data
Jin Guan
Deputy GM & Executive Directorless than a yearno datano data
Rixiang Kong
Employee Representative Supervisor & R&D Directorno datano datano data
Mingwu Yang
Head of equipment powerno datano datano data
Lisha Yang
Head of quality controlno datano datano data

6.3yrs

Average Tenure

49yo

Average Age

Experienced Management: 2563's management team is seasoned and experienced (6.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Li Tang
Co-Founder22.4yrsno data0.99%
HK$ 117.7m
Rongguo Qiu
Co- Founder22.4yrsno datano data
Cheng Zhang
Deputy GM6.3yrsno datano data
Jin Guan
Deputy GM & Executive Director1.8yrsno datano data
Rixiang Kong
Employee Representative Supervisor & R&D Director3.8yrsno datano data
Simon Guan
VP & Board Directorno datano datano data
Pai Zhu
Non-Executive Director3.2yrsno datano data
Ran Dong
Independent Non-Executive Directorless than a yearno datano data
Jin Tang
Non-Executive Directorless than a yearno datano data
Jingyao Qi
Independent Non-Executive Directorless than a yearno datano data
Songdong Meng
Independent Nonexecutive Director2.8yrsno datano data
Shufeng Zhang
Chairperson of the Supervisory Committee8.8yrsno datano data

3.2yrs

Average Tenure

49yo

Average Age

Experienced Board: 2563's board of directors are considered experienced (3.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 12:00
End of Day Share Price 2024/12/24 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Biostar Pharmaceuticals Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhishun SiuCCB International Securities Limited